MEDIUM · 5.9

CVE-2023-25962

Auth. (admin+) Stored Cross-Site Scripting (XSS) vulnerability in Biplob Adhikari Accordion – Multiple Accordion or FAQs Builder plugin <= 2.3.0 versions.

Vulnerability Description

Auth. (admin+) Stored Cross-Site Scripting (XSS) vulnerability in Biplob Adhikari Accordion – Multiple Accordion or FAQs Builder plugin <= 2.3.0 versions.

CVSS Score

5.9

MEDIUM

CVSS:3.1/AV:N/AC:L/PR:H/UI:R/S:C/C:L/I:L/A:L
Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
HIGH
User Interaction
REQUIRED
Scope
CHANGED
Confidentiality
LOW
Integrity
LOW
Availability
LOW

Affected Products

VendorProductVersions
OxilabAccordions< 2.3.1

Related Weaknesses (CWE)

References

FAQ

What is CVE-2023-25962?

CVE-2023-25962 is a vulnerability with a CVSS score of 5.9 (MEDIUM). Auth. (admin+) Stored Cross-Site Scripting (XSS) vulnerability in Biplob Adhikari Accordion – Multiple Accordion or FAQs Builder plugin <= 2.3.0 versions.

How severe is CVE-2023-25962?

CVE-2023-25962 has been rated MEDIUM with a CVSS base score of 5.9/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2023-25962?

Check the references section above for vendor advisories and patch information. Affected products include: Oxilab Accordions.